Invus Public Equities Advisors, LLC
10% owner at Scholar Rock Holding; Director at Lexicon Pharmaceuticals; 10% owner at Crescent Biopharma.
- Rank
- 269th of 809
- Companies held
- 2
- Largest holding
- SRRK, 99.9% of total
- Latest SEC filing
- Nov 25, 2024
- Listed but not counted
- $150M
What the $547M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Scholar Rock Holding SRRK Common Stock | Directly | 10,850,005 | $50.37 | $547M | 99.9% | Form 4, Nov 25, 2024 |
| Crescent Biopharma CBIO Common Stock | Directly | 63,176 split-adjusted | $12.91 | $816K | 0.1% | Form 4, Aug 8, 2024 |
Share counts are the amounts Invus Public Equities Advisors, LLC reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Invus Public Equities Advisors, LLC's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Lexicon Pharmaceuticals LXRX Common Stock | Indirectly (see filing footnote) Held by a company or fund the insider manages | 50,859,331 | $1.67 | $84.9M | — | Form 4, Aug 5, 2022 |
| Lexicon Pharmaceuticals LXRX Common Stock | Through Invus Public Equities, L.P. Held by a company or fund the insider manages | 35,402,689 | $1.67 | $59.1M | — | Form 4, Aug 5, 2022 |
| Lexicon Pharmaceuticals LXRX Common Stock | Through Invus Public Equities, L.P. Held by a company or fund the insider manages | 3,516,214 | $1.67 | $5.9M | — | Form 4, Aug 5, 2022 |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 266 | Peter E. Haas Jr. Family Fund 10% owner, Levi Strauss & | $552M |
| 267 | QH Hungary Holdings Ltd 10% owner, Quaker Chemical | $549M |
| 268 | RSS Business Management LLC Insider, Constellation Brands | $548M |
| 269 | Invus Public Equities Advisors, LLC 10% owner, Scholar Rock Holding | $547M |
| 270 | Invus Global Management, LLC 10% owner, Scholar Rock Holding | $546M |
| 271 | Magnetar Structured Credit Fund LP 10% owner, CoreWeave | $527M |
| 272 | GPI Capital Gemini HoldCo LP Director, Zeta Global Holdings | $525M |
Other Scholar Rock Holding insiders
All SRRK insiders- David Hallal$92.9MChief Executive Officer. #1576 overall
- Akshay Vaishnaw$31.8MPresident of R&D. #3321 overall
- Keith Woods$31.2MChief Operating Officer. #3664 overall
- Vikas Sinha$31.2MChief Financial Officer. #3543 overall
- Nagesh K. Mahanthappa$24.2MInterim CEO and President. #4491 overall
- Jay Backstrom$21.4MCHIEF EXECUTIVE OFFICER. #4910 overall
Questions
How much stock does Invus Public Equities Advisors, LLC own?
Invus Public Equities Advisors, LLC holds $547,330,349 in listed stock based on SEC filings and current prices, mostly Scholar Rock Holding (SRRK). That ranks 269th on the Stock Rich List.
Is this Invus Public Equities Advisors, LLC's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
Files jointly with Raymond Debbane, SEC filer 1460840, SEC filer 1841311.